Top Employer-Paid Stories
Cancer patients can't get meds as U.S. drugmakers abandon cheap generics
By Arthur AllenThe main cause, experts agree, is the underlying weakness of the generic drug industry, which are made mostly overseas because U.S. manufacturers are setting their sights instead on high-priced drugs with plump profit margins.










